8 employees
Next-generation cell-culture platform to unlock biologics manufacturing, starting with gene therapies
2021
KOLIBRI raised undisclosed on March 6, 2023
Investors: SOSV - The Accelerator VC
KOLIBRI raised undisclosed on July 6, 2022
Investors: BioTools Innovator
KOLIBRI raised undisclosed on April 13, 2021